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Summary
● Clinical and Translational Science Awards (CTSA) are large federal grants provided to an
academic institution that support education and infrastructure relevant to translational science.
● CTSA site services, training, and pilot grant funding can benefit researchers at any stage
of their career, from trainees to faculty.
● While all CTSA-funded programs offer support for research and training, the focus and
services offered vary by institution.

Introduction
Academic medical centers offer a multitude of opportunities for research. However, it can be difficult to bridge the gaps between the bench, the bedside, and the marketplace. The National
Institutes of Health (NIH) have identified this challenge, and offer Clinical and Translational
Science Awards (CTSAs) to research institutions to help spur innovations. This chapter will
explore the CTSA concept and how an academic entrepreneur can best tap into the services offered
by a CTSA, discussing Columbia’s Irving Institute as an example.

History of Clinical and Translational Science Awards
The twenty-first century brought a new dawn in the convergence of technology and scientific
medical discoveries. However, few of these discoveries are translated into improved clinical care,
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undermining achievement of one of the key goals of the NIH: “foster[ing] fundamental creative
discoveries, innovative research strategies, and their applications as a basis for ultimately protecting and improving health” (“Mission and Goals”).
In 2002, Dr. Elias Zerhouni was appointed as director of the NIH during a dynamic time: the
institute’s budget had been doubled between 1998 and 2003 (E. Zerhouni), yet only 36% of the
NIH budget was spent on clinical research and training activities (E. A. Zerhouni). Prior to joining
the NIH, Zehrouni had developed clinically relevant cancer and cardiovascular disease diagnostics. Once at the NIH, he sought to capitalize on the growth in NIH funding to address “critical
scientific gaps.” He set up discussions between legislators, administration officials, institute
directors, patient advocates, and scientific leaders to develop “the NIH roadmap,” explaining the
reorganization as follows:
The NIH earned its reputation for success because of the vitality of its institutes,
centers, and offices and because of the diverse ways in which it funds and conducts research—all fostered by decentralization inherent to its organization and
funding streams. This characteristic serves the agency well and should be
preserved. However, as science grows more complex, it is also converging on a
set of unifying principles that link apparently disparate diseases through
common biological pathways and therapeutic approaches. Today, NIH research
needs to reflect this new reality. (E. Zerhouni)
In recognition of the “new vision of healthcare,” the NIH sought a new funding model to streamline
biological research (Zerhouni and Alving). In 2005, this vision was, in part, operationalized
through a new program to fund institutional centers, the Clinical and Translational Science Award
(CTSA). The initial request for applications explained the intent of the CTSA program: “to enable
applicants to engage in innovative and transformative efforts appropriate to their own environment
that will develop and advance clinical and translational science as a distinct discipline within a
definable academic home” (Hayward). The new CTSAs were encouraged to consolidate disparate
efforts in clinical research, such as General Clinical Research Centers, T32 and T12 programs, and
other resources (Zerhouni and Alving).
The first 12 CTSA grants were awarded in 2006, and by 2008 the program had grown to 38 centers
in 23 different states, representing all geographic regions of the country. By 2009, over ten thousand researchers, 70% of whom held a doctorate, received funding administered through CTSA
grants. Subsequently, the National Center for Advancing Translational Science (NCATS) was
created in 2011 to manage the CTSA program as part of its core mission of accelerating the
translation of new treatments and cures from the lab to patients. Currently, there are 58 CTSA
centers (National Center for Advancing Translational Sciences (NCATS) FY 2020 Budget).
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A key characteristic of research funded by CTSAs is the multidisciplinary and translational nature
of the projects, with most CTSAs offering a broad range of services (Table 1). Furthermore, the
national CTSA program is supportive of entrepreneurship, with several CTSA sites emphasizing
this aspect of clinical and translational research. For example, Duke University’s CTSA has a focus
on healthcare and entrepreneurship, fostered through an active partnership with the health sector
management program at the Fuqua School of Business. A similar program at the University of
California–Davis CTSA encourages faculty entrepreneurism, intellectual property, and business
development (National Center for Research Resources) (see the chapters “Writing Business Plans
for a Life Science Startup or Clinical Program”, “Intellectual Property: Ownership and Protection
in a University Setting” and “Intellectual Property: Commercializing in a University Setting”).
Annual budgets for individual CTSA sites can vary widely, ranging from $4 million to $23 million
in 2012, for example (Briggs and Austin). The total annual budget for the CTSA program in fiscal
year 2019 from NCATS was $559 million (“Budget | National Center for Advancing Translational
Sciences”).

CTSA Site Organization
Each CTSA site is located at a U.S.-based academic health science center that has access to an
affiliated health system, usually inclusive of pediatric healthcare. Many sites are housed within
medical schools, and several are consortia of medical schools, universities, hospitals, and other
local educational and research institutions. A hallmark of the CTSA program is that each site is
given a large degree of flexibility in organizational structure to best meet its needs. Thus, CTSA
sites vary considerably with regards to the specific research services they offer; these are generally
funded by the U01 component of the CTSA (Table 1). One CTSA may offer extensive bioinformatics support, while another may choose to focus their funds on genomics. This highlights an
important point for an academic entrepreneur to keep in mind, especially if they are considering
transferring from one institution to another: the ability to conduct a research study at one CTSA
may not necessarily mean that another CTSA can provide similar services (see the chapter “Careers
in Academia and Industry: Transitions and Challenges”). Also, CTSAs have different cost
structures for their services, such that one CTSA may have reduced charges for using outpatient
research suites for certain types of research studies, while another may have higher charges for
those same studies.
Table 1. Examples of Research Services That May Be Available at a CTSA Site.
Service

Core Facilities

https://repository.upenn.edu/ace/vol1/iss5/5
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●
●
●
●

Translational technologies
Laboratory services
Embryonic cell lines
Nanotechnology
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Biomedical Informatics

Pilot Funding

Regulatory Support

Biostatistics Support

Participant and Clinical Interaction
Resources
Community Engagement Resources

●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●

Epigenomics
Behavioral data analysis
Geographic coding
Proteomics
Customized software
Institutional pilots
Trainee and scholar pilot programs
Partnerships with industry and not-for-profit programs
Auditing and compliance measures
HIPAA compliance
Conflict-of-interest management
IRB agreements
Protocol development
Adaptive trial design
Randomization and blinding
Statistical modeling and analysis
Cost recovery planning
Case report form development
Research nurse support
Adult literacy assessment
Cultural competency training
Public databases

Source: Adapted from Leshner (Leshner et al.)

In addition to these research services, a core mission of the CTSA program is to support training
the research workforce. This is generally accomplished through KL2 (for researchers with an MD,
PhD, or equivalent) and optional TL1 (for predoctoral trainees) awards, which provide access to
the following components (“Scholar and Research Programs | National Center for Advancing
Translational Sciences”):
● Clinical research mentor expertise
● Access to biomedical research specialized equipment and databases
● Training through courses, seminars, and workshops
● Administrative support for research protocols
● Pilot research project funding
Examples of training programs available through a CTSA include master’s or certificate degrees
in translational research; these also vary widely by institution.
Each CTSA is also required to establish and maintain an external advisory committee that meets
annually to discuss structure, progress, and challenges of the program and its research (Leshner et
al.). Some CTSAs also host internal advisory committees and other advisory and governance structures, such as executive committees and community advisory boards.
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The NIH tasked CTSAs with developing a national consortium to identify optimal research
practices. Originally, this comprised a consortium steering committee staffed by CTSA primary
investigators. From this main committee, subcommittees were formed around NIH-identified
priorities like education, informatics, and regulation. At this time, there are an additional three
main leadership committees (see Table 2).
Table 2: CTSA Committees.
Committee

Consortium Executive
Committee
Consortium Steering
Committee

Consortium Child
Health Oversight
Committee

Membership Size

Membership Type

Purpose

Setting strategic goals

230 total members; 60
voting members

PIs from each CTSA
institution,
representatives from
NCATS
PIs, pediatric
researchers, and staff

31 total members; 21
voting members
175 total members; 85
voting members

PIs, staff, and other

Main governing body

Promoting child health
and research

Source: Adapted from Berglund and Tarnatal (Berglund and Tarantal)

How Academic Entrepreneurs Can Access Support from
Their CTSA Site

As noted earlier, a CTSA may provide several services that could be of use to an academic entrepreneur (Table 1). Broadly speaking, these include the following:
● Educational opportunities: As noted earlier, these are often provided by the KL2 or TL1
awards, or through dedicated workshops or other training events sponsored by the
institution’s CTSA award.
● Research facilities: These may include inpatient or outpatient suites for research study
visits and specialized lab equipment. They may also provide access to research nurses and
other trained staff, such as research echocardiography technicians, dieticians, etc., as well
as core lab services and specimen storage.
● Specialized expertise: This often includes biostatistics and bioinformatics expertise.
● Grant funding: Pilot grants and other support are usually available through a competitive
peer-reviewed process.
Because of the breadth of services offered, accessing these services can be daunting. Since each
CTSA site has a different name and organization, as a first step, an academic entrepreneur should
do an internet search for the term “CTSA” and their institution’s name. Typically, there is an option
to sign up as a member of the CTSA or receive their email announcements. In addition, CTSA
staff are often very willing to meet with researchers to discuss how the institution’s CTSA can
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benefit their specific project. One-on-one meetings are very helpful in matching the unique needs
of a specific research project with beneficial services, training, and pilot grant support. This support is available to researchers at any stage of their career, from trainee to faculty member.

Columbia University’s Irving Institute: An Example of a
CTSA Site
In 1971, the Columbia Presbyterian Medical Center received a grant from the NIH to establish a
General Clinical Research Center (GCRC), the predecessor of the CTSA award. This monetary
support provided for research space, beds, and equipment in early trials on volunteer patients; the
program was later called the Irving Center for Clinical Research. In 2006, the GCRC funding
ended, as Columbia was one of the twelve inaugural recipients of a CTSA grant. The initial award
was $54 million over five years. It allowed the Irving Institute to expand their core resources of
medical informatics and biostatistics, which has led to the current resource and core offerings:
● Administrative Core and Evaluation
● Biomarkers Core Laboratory (BCL)
● Biomedical Informatics Resource (BMIR)
● Bionutrition Research Core (BRC)
● Biostatistics, Epidemiology, and Research Design (BERD)
● Clinical Research Resource (CRR)
● Community Engagement Core Resource (CECR)
● Integrating Special Populations Resource (ISP)
● Pilot and Collaborative Studies Resource (PCSR)
● Precision Medicine Resource (PMR)
● Regulatory Knowledge and Support and Ethics Resource (RKSER)
● Training and Education (TRANSFORM)
● Translational Therapeutics Accelerator (TRx)
● Trial Innovation Network
Characteristically for CTSA centers, the Irving Institute is multidisciplinary and collaborative, incorporating multiple institutions: the New York State Psychiatric Institute, the Mailman School of
Public Health, and the Children’s Hospital of New York. While the focus of the Irving Institute is
precision medicine, it has also pioneered a translational research accelerator program, the
Columbia Technology Ventures (see the chapter “Accelerators and Incubators”). At the most
recent count, in 2017–2018, the Irving Institute CTSA served 380 researchers (including one of
the authors of this chapter) and engaged in more than 500 research projects.
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Table 3: Examples of CTSA Educational and Research Grant Support.
Grant Type

Target Audience

Type of Support

TL1

Pre- and post-doctoral
researchers

Salary and educational
support

KL2

Early career physician
researchers
Assistant professors in
clinical and basic science
Clinical fellows with
doctoral degrees
Full-time Columbia
faculty at the rank of
assistant professor

Salary and educational
support
Research supplies

Bench-to-Bedside Pilot
Award
Precision Medicine
Fellowship
Irving Scholar

Salary
Salary support

Amount of
Support

Dependent on PGY
year; $44,000–
$55,000 and
benefits for two
years
Up to $100,000 per
year for two years
$40,000 for one
year
$100,000 per year
for two years
$60,000 per year for
three years

Academic entrepreneurs at Columbia University can access support from the Irving Institute
through key funding opportunities organized by career stage (from trainees to faculty). Table 3
demonstrates examples of the types of services, training, and funding that an Irving Institute grant
could support. As noted earlier, since each CTSA is different in terms of the services it offers, the
types of grant support available also will vary.
In addition, even if the Irving Institute does not offer the services needed, an academic entrepreneur
from Columbia can still access resources at a nearby CTSA since cross-institution collaboration is
encouraged.

Conclusion
The Clinical and Translational Science Award debuted in 2006 as a funding mechanism for academic medical centers that serves to accelerate the translation of research findings into the world
of patient care. It accomplishes this mission by centralizing clinical and translational research and
education in its fifty-eight funded centers and has emerged as a key component in facilitating
research in the U.S. The CTSA program is very supportive of biomedical entrepreneurship, and
thus can be an indispensable partner for an academic entrepreneur seeking to develop new
technology and innovations in patient care.
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Resources
1. A helpful summary of the success of the CTSAs in achieving their purpose and where
they might be going in the future is provided by the National Academy of Medicine:
https://www.ncbi.nlm.nih.gov/books/NBK144067/pdf/Bookshelf_NBK144067.pdf.
2. CTSA program hubs: https://ncats.nih.gov/ctsa/about/hubs.
3. Types of funded activities under the NCATS CTSA program:
https://ncats.nih.gov/files/ctsa-funding-information.pdf.
4. Resources for career development: https://ncats.nih.gov/ctsa/about/training.
5. NIH REPORT Tutorials: https://report.nih.gov/tutorial/index.aspx.
6. NIH CTSA in Action: https://ncats.nih.gov/ctsa/action.
7. NIH Matchmaker: https://projectreporter.nih.gov/reporter_matchmaker.cfm.
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